about
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretionOverview of the metabolic syndrome; an emerging pandemic of public health significance.Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.Sibutramine effects on central mechanisms regulating energy homeostasisMetabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trialsEffect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysisLaboratory animals as surrogate models of human obesity.Effect of solvents extraction on phytochemical components and biological activities of Tunisian date seeds (var. Korkobbi and Arechti).Body weight loss with phentermine alone versus phentermine and fenfluramine with very-low-calorie diet in an outpatient obesity management program: a retrospective studyHigh-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.Pharmacokinetic pilot study of the antiangiogenic activity of standardized platycodi radix.The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agentsNeuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span.The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.Treatment of obesity: an update on anti-obesity medications.Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies.The inhibitory activity of herbal medicines on the keys enzymes and steps related to carbohydrate and lipid digestion.Obesity: prevalence, theories, medical consequences, management, and research directionsCitrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.A resistant-starch enriched yogurt: fermentability, sensory characteristics, and a pilot study in children.Pharmacotherapy for childhood obesity: present and future prospects.Melanocortin signalling and the regulation of blood pressure in human obesity.The search for compounds that stimulate thermogenesis in obesity management: from pharmaceuticals to functional food ingredients.Devices for the treatment of obesity: will understanding the physiology of satiety unravel new targets for intervention?Extraction and Characteristics of Anti-obesity Lipase Inhibitor from Phellinus linteus.Optimal Extraction Conditions of Anti-obesity Lipase Inhibitor from Phellinus linteus and Nutritional Characteristics of the Extracts.Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort.Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study.Manipulation of food intake and weight dynamics using retrograde neural gastric electrical stimulation in a chronic canine model.Food intake and body weight responses to intermittent vs. continuous gastric electrical stimulation in diet-induced obese rats.Gastric electrical stimulation using endoscopically placed mucosal electrodes reduces food intake in humans.Therapeutic potential of duodenal electrical stimulation for obesity: acute effects on gastric emptying and water intake.Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study.KMUP-1, a GPCR Modulator, Attenuates Triglyceride Accumulation Involved MAPKs/Akt/PPARγ and PKA/PKG/HSL Signaling in 3T3-L1 Preadipocytes
P2860
Q22241393-0E6678AC-36E2-45A3-BBC8-52B1ECA18CCEQ24678786-68F3A79E-3F1F-4EE1-81FE-68B8050115C3Q30366107-7CE7A6A5-092B-4BCF-BFCB-92FAE03E6BB9Q30399390-5A1BE3C4-B430-421B-9A08-E63EA289A076Q30420884-2E10CEAB-2A6B-40F4-8F16-1600FE398E16Q32126634-C9CA0912-A559-418F-A86B-B2D71924B57AQ33268258-1CBBD919-58B6-4E28-900A-F852EDD7B7B8Q33567304-ED1D3127-5E3D-45E4-9B78-B411AA79468CQ33640768-CB6FF55F-C4DB-49DA-811B-3DD470DCC595Q33739051-241D15F3-8404-49E7-8065-1CF1A25147AFQ34212924-572BA838-40E7-4FC6-9832-067F0B8CD882Q34433575-A9AE31C2-360D-41AD-8BCD-C515F0B07FABQ34620531-ED86FA81-F6BF-4103-9357-242D1EBD4B49Q34712080-4D50F13F-8336-4A39-B12D-0D60DADE52CCQ34742866-4C451C7C-F72C-492F-B25F-F5FAC7336F20Q35074214-E34A69CB-E481-4B8D-924F-EC8FFC6662D9Q35559800-46ADE281-E4BF-4C98-A941-4FDDB86AEC6AQ36183233-D70B1E74-75A1-4D91-B1DB-88B0196788C2Q36249348-60C832EA-A94E-490E-837C-8B22B505E3DBQ36377254-0D53D70F-CDC4-48B1-9A2D-CACC2B8559BFQ36462314-FC255A86-47F9-459C-AD10-5B078361C6AFQ36468087-9042F1CB-2539-46B6-AA62-0E38AAF1C4B3Q37808277-8058B98E-DF31-45CC-95CF-A6B770AFF3B2Q37939346-6A9D8A27-E7DD-4BBC-B0DC-330684B5839EQ41957252-BABF924F-CA75-486C-B63D-13FFDD840819Q42029709-8CFBCE3F-733B-4E0A-AF12-909EC9176768Q42551755-FF4EAC7B-CF43-49DD-99B5-AA23EF9717BBQ45014759-9BECAF33-BD86-4D69-88D0-9B1659606515Q45031738-81DA5175-E6AF-4BF1-B3C6-F78265BACE71Q47260282-C7025401-9908-488B-B69C-A500B1366C99Q47283679-1359D74C-0643-46E4-AA54-C7D809FCE777Q51264289-FABD48C4-C812-48D9-92BB-4EC72A0CAF10Q51524838-4C40E130-FB67-4362-85CB-AB1718335B13Q53706545-C04F4BC2-F32C-45D4-9EE8-A980CEA3D472Q58692376-CC3EDE68-3C3B-4C7E-8456-83AE264D4193
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Current and potential drugs for treatment of obesity.
@ast
Current and potential drugs for treatment of obesity.
@en
type
label
Current and potential drugs for treatment of obesity.
@ast
Current and potential drugs for treatment of obesity.
@en
prefLabel
Current and potential drugs for treatment of obesity.
@ast
Current and potential drugs for treatment of obesity.
@en
P356
P1433
P1476
Current and potential drugs for treatment of obesity.
@en
P2093
Greenway FL
P304
P356
10.1210/ER.20.6.805
P577
1999-12-01T00:00:00Z